Thrombolysis in acute stroke patients with cerebral small vessel disease

Cerebrovascular Diseases

Volumn 37, Issue 1, 2014, Pages 5-13

  Pantoni, Leonardo ^a   Fierini, Fabio ^b   Poggesi, Anna ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Hemorrhages; Microbleeds; Small vessel disease; Thrombolysis; White matter lesions

Indexed keywords

PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; LACUNAR STROKE; MULTICENTER STUDY (TOPIC); NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STROKE PATIENT; WHITE MATTER LESION;

CEREBRAL HEMORRHAGE; CEREBRAL SMALL VESSEL DISEASES; FIBRINOLYTIC AGENTS; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; RECOMBINANT PROTEINS; RISK; STROKE, LACUNAR; THROMBECTOMY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84890459956     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000356796     Document Type: Review

References (40)

1. Pantoni L: Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701.
2. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O?Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, DeCarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok, van Oostenbrugge R, Pantoni L, Speck O, Stephan BCM, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, Standards for Reporting Vascular Changes on Neuroimaging (STRIVE v1): Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838.
3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
4. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
5. IST-3 Collaborative Group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A: The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352-2363.
6. Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, Levine SR, NINDS rt-PA Stroke Study Group: Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt- PA Stroke Study. Cerebrovasc Dis 2008; 26: 120-125.
7. Fisher CM: Lacunar stroke and infarcts: a review. Neurology 1982; 32: 871-876.
8. Sacco S, Marini C, Totaro R, Russo T, Cerone D, Carolei A: A population-based study of the incidence and prognosis of lacunar stroke. Neurology 2006; 66: 1335-1338.
9. Hsia AW, Sachdev HS, Tomlinson J, Hamilton SA, Tong DC: Efficacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter? Neurology 2003; 61: 71-75.
10. Fluri F, Hatz F, Rutgers MP, Georgiadis D, Sekoranja L, Schwegler G, Sarikaya H, Weder B, M?ller F, L?thy R, Arnold M, Reichhart M, Mattle HP, Tettenborn B, Nedeltchev K, Hungerb?hler HJ, Sztajzel R, Baumgartner RW, Michel P, Lyren PA, Engelter ST: Intravenous thrombolysis in patients with stroke attributable to small artery occlusion. Eur J Neurol 2010; 17: 1054-1060.
11. Mustanoja S, Meretoja A, Putaala J, Viitanen V, Curtze S, Atula S, Artto V, Häppölä O, Kaste M, Helsinki Stroke Thrombolysis Registry Group: Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis. Stroke 2011; 42: 102-106.
12. Fuentes B, Martínez-Sánchez P, Alonso de Leciñana M, Egido J, Reig-Roselló G, Díaz- Otero F, Sánchez V, Simal P, Ximenez-Carrillo A, García-Pastor A, Ruiz-Ares G, García- García A, Masjuan J, Vivancos-Mora J, Gil- Nuñez A, Díez-Tejedor E, Madrid Stroke Network: Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data. Eur J Neurol 2012; 19: 1568-1574.
13. Shobha N, Fang J, Hill MD: Do lacunar strokes benefit from thrombolysis? Evidence from the Registry of the Canadian Stroke Network. Int J Stroke 2013; 8(suppl A100):45-49.
14. Toni D, Iweins F, von Kummer N, Busse O, Bogousslavsky J, Falcou A, Lesaffre E, Lenzi GL, ECASS I Group: Identification of lacunar infarcts before thrombolysis in the ECASS I study. Neurology 2000; 54: 684-688.
15. Derex L, Nighoghossian N: Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry 2008; 79: 1093-1099.
16. Álvarez-Sabín J, Maisterra O, Santamarina E, Kase C: Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol 2013; 12: 689-705.
17. National Institute of Neurological Disorders and Stroke t-PA Stroke Study Group: Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997; 28: 2109-2118.
18. Leblanc R, Haddad G, Robitaille Y: Cerebral hemorrhage from amyloid angiopathy and coronary thrombolysis. Neurosurgery 1992; 31: 586-590.
19. Inzitari D, Giordano GP, Ancona AL, Pracucci G, Mascalchi M, Amaducci L: Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke 1990; 21: 1419-1423.
20. Wong KS, Chan YL, Liu JY, Gao S, Lam WW: Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology 2003; 60: 511-513.
21. Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group: A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997; 42: 857-865.
22. Gorter JW: Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention in Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999; 53: 1319-1327.
23. Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM: Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 2002; 59: 193-197.
24. Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A, Humpich M, Kastrup A, Kucinski T, Lecei O, Liebeskind DS, Rother J, Rosso C, Samson Y, Saver JL, Yan B, MR Stroke Group: Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 2006; 37: 2463-2466.
25. Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM, CASES Investigators: Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007; 68: 1020-1024.
26. van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J: Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990; 53: 1080-1083.
27. Ariës MJH, Uyttenboogaart M, Vroomen PC, de Keyser J, Luijckx GJ: tPA treatment for acute ischaemic stroke in patients with leukoaraiosis. Eur J Neurol 2010; 17: 866-870.
28. LADIS Study Group: 2001-2011: a decade of the LADIS (Leukoaraiosis and Disability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 2011; 32: 577-588.
29. Kobayashi A, Karlinski M, Litwin T, Czlonkowska A: Do silent infarcts modify the effect of thrombolysis for stroke? Acta Neurol Scand 2013; 127: 227-232.
30. Shi ZS, Loh Y, Liebeskind DS, Saver JL, Gonzalez NR, Tateshima S, Jahan R, Feng L, Vespa PM, Starkman S, Salamon N, Villablance JP, Ali LK, Ovbiagele B, Kim D, Viñuela F, Duckwiler GR: Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke 2012; 43: 1806-1811.
31. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, Leary MC, Starkman S, Gobin YP, Jahan R, Vespa P, Liebeskind DS, Alger JR, Vinuela F: Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 2002; 33: 95-98.
32. Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, Honnorat J, Yilmaz H, Dardel P, Froment JC, Trouillas P: Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis 2004; 17: 238-241.
33. Kakuda W, Thijs VN, Lansberg MG, Bammer R, Wechsler L, Kemp S, Moseley ME, Marks MP, Albers GW, DEFUSE Investigators: Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 2005; 65: 1175-1178.
34. Kim HS, Lee DH, Ryu CW, Lee JH, Choi CG, Kim SJ, Suh DC: Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol 2006; 186: 1443-1449.
35. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, Kim JS, Liebeskind DS, Neumann- Haefelin T, Pedraza S, Rother J, Rothwell P, Rovira A, Schellinger PD, Trenkler J, MR STROKE Group: Bleeding Risk Analysis in Stroke Imaging before Thrombolysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 2007; 38: 2738-2744.
36. Charidimou A, Kakar P, Fox Z, Werring DJ: Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2013; 84: 277-280.
37. Shoamanesh A, Kwok CS, Lim PA, Benavente OR: Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and metaanalysis. Int J Stroke 2013; 8: 348-356.
38. Cordonnier C, Al-Shahi Salman R, Wardlaw J: Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007; 130: 1988-2003.
39. Görner A, Lemmens R, Schrooten M, Thijs V: Is leukoaraiosis on CT an accurate surrogate marker for the presence of microbleeds in acute stroke patients? J Neurol 2007; 254: 284-289.
40. Norrving B: Long-term prognosis after lacunar infarction. Lancet Neurol 2003; 2: 238-245.